MD Biosciences Neuro Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
MD Biosciences Neuro is a Cambridge, Massachusetts–based preclinical contract research organization focused on neuroscience, with an emphasis on pain and neurodegenerative diseases. Its GLP-certified laboratory supports studies assessing cognition, memory, pain, sensorimotor function, and related endpoints, and it offers pig models to bridge preclinical and clinical work alongside traditional rodent models. The company adds innovative approaches such as specialized evaluations and electrophysiology to generate clinically relevant data for its customers. Target clients are researchers and companies conducting CNS and pain-related translational research, seeking endpoints aligned with patient outcomes to strengthen preclinical findings. In addition to its core services, the firm highlighted a recent development involving a novel dry ice stimulation method, announced in mid-2024, underscoring its ongoing methodological development in the field.